Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
2 Medical Stocks to Consider Buying in June
09:52pm, Wednesday, 28'th Jun 2023
With solid top and bottom-line growth on the horizon for HealthEquity (HQY) and iRadimed (IRMD), they are starting to look like viable investments for 2023 and beyond.
Pfizer: Come For The Dividend - Stay For The Dividend
03:51pm, Wednesday, 28'th Jun 2023
Pfizer's share price is going nowhere - the float is too big. Even after COVID allowed the company to generate >$100bn in revenues, it is back on the slide again. The company has spent ~$70bn on M&A a
FDA Accepts Pfizer's (PFE) Hemophilia B Gene Therapy Filing
10:36am, Wednesday, 28'th Jun 2023
A final decision on Pfizer's (PFE) BLA filing, seeking approval for hemophilia B gene therapy, treatment is expected by second-quarter 2024.
US FDA approves Pfizer's drug for growth hormone deficiency
07:10am, Wednesday, 28'th Jun 2023
The U.S. Food and Drug Administration has approved Pfizer Inc and partner OPKO Health Inc's treatment for growth hormone deficiency in children, the companies said on Wednesday.
Pfizer wins FDA approval for once-weekly human growth hormone treatment for children aged three and older
06:56am, Wednesday, 28'th Jun 2023
Pfizer Inc. PFE, -1.27% said Wednesday the U.S. Food and Drug Administration has approved its Ngenla once-weekly, human growth hormone treatment for children aged three and older who have growth failu
3 Pharma Stocks That Have Big Investors Running for the Exit
06:00am, Wednesday, 28'th Jun 2023
Pharmaceutical stocks are trailing the market this year. So far in 2023, the Dow Jones U.S. Select Pharmaceuticals Index is down 5.4% while all three major indices are positive on the year.
Andreas Halvorsen Curbs Roivant Sciences Stake
05:53pm, Tuesday, 27'th Jun 2023
Andreas Halvorsen (Trades, Portfolio), the chief investment officer of Viking Global Investors, disclosed earlier this week he reduced his stake in Roivant Sciences Ltd. ( ROIV , Financial) by 14.73%.
3 Blue-Chip Dividend Stocks That Will Double in One Year
04:26pm, Tuesday, 27'th Jun 2023
In general, when we talk about a quick doubling time, it's associated with growth stocks or penny stocks. Blue-chip stocks are known for steady upside and robust dividends.
Pfizer obesity and diabetes drug danuglipron faces major challenges in coming to market, analysts warn
02:57pm, Tuesday, 27'th Jun 2023
The path to market for Pfizer's drug danuglipron (danu) for obesity and type 2 diabetes looks “extremely challenging” as its development lags one to two years behind its top competitors, analysts
Lilly, Pfizer and Others Are Working on Obesity Pills. What to Know.
01:35pm, Tuesday, 27'th Jun 2023
Lilly investors are upbeat on injectable weight-loss treatment Mounjaro, but the pills—easier to take, cheaper to make—might have the biggest long-term impact.
Pfizer (PFE) Stock Down on Halting Development of Obesity Drug
12:03pm, Tuesday, 27'th Jun 2023
Shares of Pfizer's (PFE) fell 3.7% on Monday after management's decision to terminate the development of an experimental obesity pill following concerns over liver safety.
Factbox: Weight-loss drugs: the next gold rush
10:56am, Tuesday, 27'th Jun 2023
Drug developers are chasing an obesity drug gold rush that may be worth up to $100 billion by rolling out treatments that can help lose as much as 24% of weight in less than a year.
New developments in weight-loss drugs: Novo Nordisk, Eli Lilly & Pfizer advance studies
07:40am, Tuesday, 27'th Jun 2023
Dr. Angela Fitch, Knownwell chief medical officer and president of Obesity Medicine Association, joins 'Squawk Box' to discuss the advances in weight-loss drugs, what it means for the obesity epidemic
BMO's Evan Seigerman says Pfizer's dip is a setback and not catastrophic
05:46pm, Monday, 26'th Jun 2023
Evan Seigerman, BMO, joins 'Closing Bell' to discuss Pfizer ending its development of an experimental obesity drug.
Pfizer stock drops after company picks twice-daily weight loss pill candidate
05:44pm, Monday, 26'th Jun 2023
Yahoo Finance reporter Anjalee Khemlani reports the latest news on Pfizer weight loss drugs.
